Try our beta test site
1 study found for:    24081937 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer
Condition: Carcinoma, Hepatocellular
Interventions: Drug: sunitinib malate;   Drug: sorafenib

Study has passed its completion date and status has not been verified in more than two years.